[LGND] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 91.44%
YoY- 95.03%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 17,701 14,973 13,005 6,375 5,741 7,802 7,901 14.38%
PBT 7,284 901 2,025 -52 -3,884 -11,436 1,055 37.97%
Tax -217,255 124 60 142 22 419 -748 157.23%
NP 199,165 1,280 1,965 -194 -3,906 -11,843 1,803 118.96%
Tax Rate 2,982.63% -13.76% -2.96% - - - 70.90% -
Total Cost -181,464 13,693 11,040 6,569 9,647 19,645 6,098 -
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 1,125.16 8.55 15.11 -3.04 -68.04 -151.79 22.82 91.43%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS 10.01 0.06 0.10 -0.01 -0.20 -0.60 0.12 108.95%
EPS Diluted 9.28 0.06 0.09 -0.01 -0.20 -0.60 0.12 106.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.